The Marked Chart Wire · Business
GSK
GSK beats third quarter earnings estimates
GlaxoSmithKline reported third quarter results that exceeded expectations and reaffirmed its full year 2026 financial outlook.
The stocks in this story
Prices from Before the open · based on Tue close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
More Business news
GE HealthCare
GE HealthCare beats estimates and raises full-year outlook
The company reported non-GAAP earnings of $1.34 per share, exceeding expectations by $0.14. Revenue reached $5.51 billion, topping forecasts by $160 million, while management increased its annual guidance.
Meta
Canaccord sees 53 percent upside for META shares
Meta shares dropped 11 percent last week after Q3 results showed negative free cash flow and a proposed $97 billion asset sale. Canaccord analysts maintain a positive outlook on the stock.
Stellantis
Stellantis reports $4.5 billion cash shortfall in third quarter
The European automaker disclosed a 4 billion euro cash drain during the period as it executes its ongoing turnaround strategy.
Biogen
Biogen narrows 2026 adjusted earnings guidance
Biogen revised its full-year 2026 adjusted earnings per share outlook to a range of $15.95 to $16.75, down from the previous $15.85 to $16.85. The new midpoint sits above the $12.36 analyst estimate.
UMC Earnings
United Microelectronics misses third quarter earnings and sales estimates
The chipmaker reported third-quarter earnings per share of $0.21, below the $0.23 expected by analysts. Revenue came in at $2.32 billion, falling short of the $2.35 billion forecast.
Robinhood
Robinhood stock slides on crypto drag despite strong sales
The firm's quarterly revenue matched forecasts, boosted by expansion into options and prediction markets. However, falling crypto prices reduced overall profits, countering gains from these newer service lines.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.